Impact of exercise training in combination with Dapagliflozin on physical function in adults with type 2 diabetes mellitus: study protocol for the Dapagliflozin, Exercise Training and physical function (DETA) randomised controlled trial

Introduction: Sodium-glucose co-transporter 2 inhibitors (SGLT2i) are associated with weight loss, diverse cardiorenal benefits and improved glycaemic control. However, the effects of SGLT2i on physical function and fitness are uncertain. The Dapagliflozin, Exercise Training and physicAl function (D...

Full description

Saved in:
Bibliographic Details
Main Authors: Jack A. Sargeant, Ehtasham Ahmad, Emily James, Luke Baker, Joanna M. Bilak, Nicole A. Coull, Gaurav S. Gulsin, James King, Kamlesh Khunti, Emma Redman, Alex V. Rowlands, Emma Watson, Joanne Wormleighton, Gerry P. McCann, Thomas Yates, Melanie J. Davies
Format: Default Article
Published: 2024
Subjects:
Biomedical and clinical sciences
Clinical sciences
Health sciences
Other health sciences
Psychology
Dapagliflozin
Exercise
Frailty
Type 2 diabetes
Physical funtion
Diet
Sodium-glucose co-transporter 2 inhibitor (SGLT2i)
Randomised controlled trial
T2DM
Diabetes and endocrinology
Online Access:https://hdl.handle.net/2134/27270420.v1
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://hdl.handle.net/2134/27270420.v1

Similar Items